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ABSTRACT 
The retrovirus, human immunodeficiency virus type 1 (HIV-1), possesses a positive 
sense RNA genome (gRNA) that is reverse transcribed into proviral DNA upon infection. 
In order for reverse transcription to occur, HIV-1 co-opts cellular tRNALys3, whose 3´ 18 
nucleotides are perfectly complimentary to a region with the gRNA, to serve as the 
primer. tRNALys3 is selectively packaged into virions through its interaction with the 
cellular enzyme lysyl-tRNA synthetase (LysRS), which in turn interacts with the viral 
protein responsible for orchestrating virus assembly, Gag. However, the mechanism of 
tRNALys3 transfer from the packaged LysRS to the primer-binding site (PBS) remains 
incompletely understood. The PBS is harbored in the 5´ untranslated region (5´UTR) of 
the gRNA, a highly conserved segment of the HIV-1 genome. We have recently found 
that a U-rich stem loop immediately upstream of the PBS mimics the anticodon loop 
nucleotides of tRNALys3, a critical LysRS recognition element. This tRNA-like element 
(TLE) specifically binds to LysRS, and can competitively displace tRNALys3 from the 
synthetase. Furthermore, small angle X-ray scattering analysis revealed that the whole 
PBS domain (PBS105) mimics the overall 3D shape of tRNA.  Overall, these data suggest 
a mechanism where structural and functional tRNA mimicry by the TLE in the PBS 
domain facilitate primer release from LysRS and targeting to the 18 nucleotide PBS.  
An observation from the structural analysis was that both apoPBS and PBS annealed to a 
DNA oligonucleotide corresponding to the 18 complementary nucleotides in tRNALys3 
(antiPBS18) mimicked the overall tRNA shape to a similar degree.  In order to further 
investigate the function of the PBS/TLE domain, we performed a fluorescence 
anisotropy-based binding study examining LysRS interactions with the PBS domain in 
various functionally relevant states. We find LysRS has similar affinities for both the 
apoPBS105 and PBS105:antiPBS18 complex, confirming the SAXS structure indicating 
both complexes mimic tRNA shape. In order to investigate if the additional tRNA-gRNA 
contacts outside of the 18 nucleotides of complementarity affected the LysRS interaction, 
we tested PBS105:primer complexes containing full-length and 3´-half tRNAs, finding 
that PBS:tRNA primer complexes displayed reduced affinities for LysRS under certain 
conditions. Also, when progressively extended antiPBS18 primers were annealed to 
PBS105, mimicking the initial steps of reverse transcription, we observed a concomitant 
drop in LysRS affinity. These data further elucidate the role that LysRS plays in the 
evolution of the reverse transcription initiation complex.  
  
INTRODUCTION 
Human immunodeficiency virus type 1 (HIV-1) possesses a positive-sense RNA genome 
(gRNA) that is reverse transcribed into cDNA upon infection of susceptible 
lymphocytes1. This process is carried out by HIV-1 reverse transcriptase which, in order 
to initiate polymerization, requires a primer. In the case of HIV-1, cellular tRNALys3 is 
co-opted by the virus to serve in this regard2. Interestingly, the primer tRNALys3 is not 
recruited in the actively infected cell, and rather originates from the virus progenitor cell. 
While only tRNALys3 is able to serve as the primer for reverse transcription, all three 
tRNALys isoacceptors are incorporated into virions at levels significantly enriched over 
those found in the cytoplasm3,4.  
The canonical role for tRNALys is in protein synthesis, where a tRNALys molecule 
covalently linked to the amino acid lysine is used by the ribosome to decode lysine 
codons in mRNA transcripts5. Correct aminoacylation of tRNALys is carried out by lysyl-
tRNA synthetase (LysRS), and LysRS is the only cellular factor known to bind all three 
tRNALys isoacceptors at equivalent levels4. It was demonstrated that LysRS is selectively 
packaged into virions, and its upregulation and downregulation correlate positively and 
negatively with virus viability, respectively. Furthermore, LysRS downregulation leads to 
diminished packaging of tRNALys. LysRS has been shown to interact specifically with the 
capsid domain of the viral protein Gag, both in vitro and in vivo4; Gag is the primary 
driver of virion formation, and its expression alone is sufficient to make virus like 
particles6. While Gag alone is sufficient to incorporate LysRS into virions, both Gag and 
GagPol are required for tRNA packaging4. Taken together, these data support a model 
whereby LysRS is responsible for mediating the interaction between the viral proteins 
principally responsible for assembly (i.e. Gag and GagPol) and primer tRNALys3, 
ensuring its selective incorporation.  
The primer binding site (PBS) that tRNALys3 anneals to in order to initiate revere 
transcription is found in the 5´ 
untranslated region (5´UTR) of the 
gRNA (Figure 1). It is still not known 
precisely at what point during the viral 
life cycle tRNALys3 associates with the 
PBS. Another poorly understood aspect 
of this mechanism is the means by which 
LysRS:tRNALys3 correctly localize to the 
PBS and transfer tRNA from LysRS to 
the PBS, as well as what happens to 
LysRS once this transfer is complete. Recently, we have shown that a tRNA-like element 
(TLE) immediately upstream of the PBS shares a similar sequence to the anticodon of 
tRNALys3, and is capable of competitively displacing tRNA from LysRS7. We also 
showed that the whole PBS domain mimics the overall 3D shape of a tRNA8. 
Interestingly, even upon annealing of a DNA oligonucleotide corresponding to the 18 
complementary nucleotides in tRNALys3 (antiPBS18), the PBS domain maintained its 
tRNA-like structure. The implications of this result on the presence/absence of LysRS in 
the PBS:primer complex remain unknown.	   
In the present work, we use a fluorescence anisotropy-based binding assay to further 
investigate the interaction of LysRS with the PBS domain in various functionally relevant 
Figure 1: Predicted secondary structure of the 105-
nucleotide PBS domain (PBS105). The actual 18-nucleotide 
site of tRNA primer annealing is indicated in grey, and the 
location of the 10 base pair extension of the TLE stem 
loop (PBS105-TLE extension) is indicated in the inset. 
states. We find that, consistent with the structural observations, there is no significant 
difference in the affinity of LysRS for apo vs. antiPBS18 primer annealed PBS domains. 
However, when we use tRNA primers or primers meant to mimic the initial steps of 
reverse transcription, we observe a drop in LysRS affinity for the complex. The 
implications of this finding regarding the presence of LysRS in the initiation complex are 
discussed. 
 
MATERIALS AND METHODS 
Preparation of proteins and nucleic acids 
Human LysRS9 was prepared as previously described7. Briefly, LysRS contains a His6 
tag and was purified using Ni2+ or Co2+ resins. Protein concentration was determined 
using a Bradford assay (Bio-Rad).  
All DNA constructs used in this study (antiPBS18, antiPBS18+3, antiPBS18+6, and 
antiPBS18+11) were purchased from IDT (Coralville, IA), and used without further 
purification. All RNAs used—PBS105, PBS105-TLE extension, tRNALys344, and 
tRNALys376—were prepared by in vitro transcription using T7 RNA polymerase and 
purified using denaturing (8 M urea) polyacrylamide gel electrophoresis. The genes 
encoding these RNAs have previously been described7, and all RNAs, except tRNALys344, 
were transcribed from FokI-digested plasmid that generated the appropriately sized DNA 
template. In the case of tRNALys344, primers containing the T7 promoter were used to 
amplify the desired DNA sequence from the tRNALys376 gene, and then used as template 
for in vitro transcription. Prior to any experiment, the RNA or RNA:RNA/DNA complex 
was folded by heating to 80˚C for 2 min, 60˚C for 4 min, adding MgCl2 to 10 mM, 
incubating at 37˚C for 6 min, and cooling on ice for at least 30 min.  
Fluorescently labeled RNAs were generated essentially as previously described7,10, 
except that 1.5-2.5 nmol RNA was treated with 20-fold excess sodium periodate, and 5 
mM fluorescein-5-semithiocarbazide was used. Labeling efficiencies were typically 
greater than 80%.  
 
Native gel shift annealing assays  
Fluorescently labeled PBS105 RNA (568 nM) was folded as described above in the 
presence of varying amounts of antiPBS18, tRNALys344, or tRNALys376, (relative 
stoichiometries in Figure 2 legend). This was then diluted to final solution conditions 
closely approximating those of the anisotropy binding assays (20 mM Tris-HCl pH 8, 10 
mM MgCl2, 35 mM KCl, 15 mM NaCl, and 10 mM HEPES pH 7.5) plus native loading 
dye (50% glycerol, xylene cyanol, and bromophenol blue), and resolved on a 12% native 
polyacrylamide gel. Gels were then imaged on a Typhoon Trio phosphorimager (GE 
Healthcare) using fluorescein dye specific excitation and emission wavelengths as 
described7. Band intensities were quantified using ImageJ software.  
 
Fluorescence anisotropy equilibrium binding assays  
Fluorescently labeled PBS105 or PBS105-TLE extension RNA was refolded as described 
above in the absence or presence of other nucleic acids (at varying stoichiometric ratios, 
indicated in results section). Reactions were then diluted to final conditions (20 mM Tris-
HCl pH 8, 10 mM MgCl2 or 1 mM MgCl2, 35 mM KCl, 15 mM NaCl, 5 mM HEPES pH 
7.5, 30 nM RNA or RNA:RNA/DNA complex, and various protein concentrations), and 
incubated at room temperature for at least 30 min. Resulting fluorescence intensity and 
anisotropy was read in 384-well plates using a SpectraMax M5 plate reader (Molecular 
Devices) by exciting at 485 nm, and measuring emission at 525 nm with a emission 
cutoff of 515 nm. For each protein titration point, three (20 µL) aliquots were read to 
control for device measurement variation, and each titration itself was repeated in at least 
three independent trials. Binding curves were fit to a 1:1 binding model as previously 




Mammalian LysRS proteins contain a 65 amino acid N-terminal domain that has been 
shown to contribute non-specifically to RNA binding. Given that mammalian LysRS is 
more sensitive to differences in specific RNA interactions without this domain 
(LysRS∆N65)12, and that we have previously shown that both human LysRS-wt and 
human LysRS∆N65 bind to PBS/TLE RNA7, we elected to carry out all further studies 
using the human LysRS∆N65 construct (which will henceforth simply be referred to as 
LysRS).  
We used a fluorescence anisotropy assay to measure the binding affinity of LysRS to the 
various nucleic acids and nucleic acid complexes examined in this work. We began by 
testing LysRS affinity for the apo form of the PBS domain (apoPBS105), and observed an 
apparent Kd of 423 nM at 1 mM [MgCl2] (plus other solution conditions listed in 
materials and methods section). We wanted to see how increasing the stringency of the 
salt conditions would affect the strength of the observed Kd, so we performed the same  
experiment except that we increased [MgCl2] to 10 mM. Under these conditions we 
observed approximately 
two-fold increase in Kd 
up to 866 nM. Moving 
forward we tested most 
interactions both at 1 mM 
and 10 mM [MgCl2] 
conditions (results of all 
binding data are 
summarized in Table 1). 
In order to test the importance of the tRNA-like shape of the PBS domain for binding to 
LysRS, independent of its anticodon sequence mimicry, we extended the TLE stem loop 
by 10 base pairs while keeping the anticodon loop the same (PBS105-TLE extension, 
Figure 1), and determined LysRS affinity. We find that there is a negligible drop in 
affinity under the 1 mM [MgCl2] conditions (423 nM for PBS105 to 593 nM for PBS105-
TLE extension), while there is a more significant two-fold decrease under the more 
stringent 10 mM [MgCl2] conditions (866 nM for PBS105 to 1450 nM for PBS105-TLE 
extension). This suggests that the overall tRNA-like shape of PBS is contributing, at least 
in part, to LysRS binding. 
Given our previous structural observation that annealing of antiPBS18 to the PBS domain 
did not lead to a significant structural change in the TLE stem8, we wanted to test if 
LysRS affinity for the complex would remain similarly unchanged. First, however, we 
Table 1: Apparent equilibrium dissociation constants (Kd) for human LyRS∆N65
binding to RNAs or RNA complexes.
RNA Kd, nM (1 mM MgCl2) Kd, nM (10 mM MgCl2)
apoPBS105 423 ± 108 866 ± 57
PBS105-TLE extension 593 ± 84 1450 ± 241
PBS105:antiPBS18 (1:1.5)a ND 787 ± 143
PBS105:antiPBS18 374 ± 24 760 ± 260
PBS105:tRNALys344 961 ± 81 724 ± 71
PBS105:tRNALys376 643 ± 59 666 ± 178
PBS105:antiPBS18+3 402 ± 212 ND
PBS105:antiPBS18+6 704 ± 78 ND
PBS105:antiPBS18+11 1320 ± 223 ND
All measurements were performed with 30 nM RNA/RNA complex in 15 mM 
NaCl, 35 mM KCl, 20 mM Tris-HCl pH 8, and either 1 or 10 mM MgCl2 
(indicated above).
Results are the average of at least three trials ± the standard deviation.
aAll RNA complexes were tested at 1:1 stoichiometric ratios, except this trial 
which was tested at 1:1.5 PBS:primer ratios.
ND = not determined
LysRS∆N65
wanted to confirm that we were achieving complete complex formation under our assay 
conditions. Thus, we performed native polyacrylamide gel shift-annealing assays to 
determine the optimal stoichiometries at which to carry out the LysRS binding studies. 
We examined the formation of PBS105:antiPBS18, PBS105:tRNALys344, and 
PBS105:tRNALys376 complexes in these experiments, and found that at PBS:primer 
stoichiometric ratios of 1:1 there was ~90% homogenous complex formation and at 1:1.5 
ratios there was ~100% homogenous complex formation (Figure 2).  We suspected that 
using either the 





so we tested 
PBS105:antiPBS18 at both ratios for their affinity towards LysRS under the 10 mM 
[MgCl2] conditions, finding that they possess nearly indistinguishable Kd values (760 nM 
at 1:1 ratios and 787 nM at 1:1.5 ratios, Table 1). In order to alleviate any concern about 
the excess primer present in the 1:1.5 stoichiometric condition, we elected to carry out all 
further experiments at the 1:1 PBS:primer ratios. Importantly, we show that regardless of 
[MgCl2], there is little difference between measured Kd’s of apoPBS105 and 
PBS105:antiPBS18 (Table 1), confirming the structural observation that the TLE stem loop 
and overall tRNA-like shape of the PBS domain remain unchanged upon antiPBS18 
primer annealing.  
1:0$ 1:0.5$$$ 1:1$ $$1:1.5$$$ 1:0$ 1:0.5$$$1:1$ $$1:1.5$$$ 1:0$ 1:0.5$$$1:1$ $$1:1.5$$$
PBS:tRNALys,376$PBS:tRNALys,344$PBS:an8PBS18$
%$Annealed:$ 0%$ 57%$ 87%$ 95%$ 3%$ 49%$ 82%$ 100%$ 14%$ 53%$ 92%$ 100%$
PBS:primer:$
Figure 2: Native-PAGE analysis of various PBS:primer complexes, revealing 
homogenous complex formation and high amounts of annealed complex. 
We next wanted to investigate if the annealing of primers more closely resembling the 
authentic tRNALys3 primer would lead to differences in LysRS affinity. Indeed, additional 
contacts between the tRNA and viral RNA outside of the 18 nucleotides of 
complementarity have been proposed to occur13,14. Our tRNALys344 construct is composed 
of the final 44 nucleotides on the 3´ half of tRNALys3, and possesses all of the nucleotides 
theoretically required to make these additional interactions with the PBS domain (Figure 
3). We began by testing PBS105:tRNALys344 complexes at 1:1 stoichiometric ratios for 
their affinity to LysRS. Our results show that under the 10 mM [MgCl2] conditions there 
is little difference between no primer and antiPBS18 or tRNALys344 as the primer (866 nM, 
787 nM, 760 nM, respectively), while at the 1 mM [MgCl2] condition there is a ~3-fold 
drop in affinity (to 961 nM) when tRNALys344 is used as the primer compared to the apo 




ACCGCGGGCTTGTCCCTG 5´' Figure 3: Figure illustrating the PBS 
domain in complex wi th the 
antiPBS18, tRNALys344, and tRNALys376 
primers. tRNALys344 and tRNALys376 
are predicted to make additional 
contacts with the PBS domain not 
shown here.   
full-length tRNALys376 is used as the primer, we similarly observe little change in Kd at 10 
mM [MgCl2] (666 nM), while under the 1 mM [MgCl2] conditions LysRS binds 
PBS105:tRNALys376 more weakly by about 2-fold (643 nM) vs. apoPBS105 or 
PBS105:antiPBS18  (423 nM and 374 nM, Table 1). These results indicate that LysRS 
affinity for the PBS:primer complex does decrease upon primer annealing if a tRNA 
construct capable of making additional contacts with the PBS is used, but only under the 
less stringent solution conditions. This result is further discussed later on. 
We next wanted to investigate how the early steps of reverse transcription would affect 
LysRS affinity for the PBS:primer complex. In order replicate this situation, we annealed 
a series of DNA primers containing the antiPBS18 sequence plus varying numbers of 
additional nucleotides complimentary to the PBS sequence at the 3´ end of the primer 




Figure 4: Figure illustrating the PBS domain in 
complex with the antiPBS18+3, antiPBS18+6, and 
antiPBS18+11 primers. The additional base pairs 
that these DNAs make with the TLE stem are 
also indicated.  
experiments were only carried out under the 1 mM [MgCl2] conditions. We found that 
PBS105:antiPBS18+3 bound LysRS with similar affinity as apoPBS105 or PBS105:antiPBS18 
(all around ~400 nM, Table 1). However, PBS105:antiPBS18+6 bound LysRS more 
weakly (Kd = 704 nM), and PBS105:antiPBS18+11 even more weakly (Kd = 1320 nM). 
This result is consistent with the TLE being the main site of LysRS interaction, as it is 
only when TLE integrity is disrupted by the +6 and +11 primers that we observe a drop in 
LysRS affinity.  
 
DISCUSSION 
In this work we have shown that LysRS interacts with the PBS domain due at least in part 
to tRNA structural mimicry. Furthermore, we have found that the identity of the primer 
annealed to the PBS domain affects the strength of the LysRS interaction, and that those 
primers mimicking the early steps of reverse transcription lead to diminished LysRS 
binding. The fact that annealing of primers more closely resembling authentic tRNALys3 
lead to reduced LysRS affinity makes sense as once the tRNA primer is annealed, 
LysRS’s presence would seem to be dispensable in the reverse transcription initiation 
complex. It is interesting to note that LysRS affinity only decreases under the less 
stringent MgCl2 conditions. This could be caused by the higher [MgCl2] leading to 
incomplete formation of the additional contacts made in the PBS:tRNA complex. Indeed, 
the formation of these additional contacts appears to be more difficult to make, and 
unmodified tRNALys3 does not make them as efficiently14. One of the additional PBS-
tRNALys3 contacts occurs between the TLE stem loop of PBS and the variable 
loop/anticodon loop of tRNA15. Therefore, it is plausible that the reason that tRNALys344 
and tRNALys376 only cause a decrease in LysRS affinity under the 1 mM MgCl2 
conditions is because it is only under these conditions that the additional PBS-tRNA 
contacts in the TLE region are made, thus disrupting the putative LysRS binding site.  
The importance of the TLE stem loop as the bona fide LysRS binding site is further 
supported by the evidence that only antiPBS18+6 and +11 primers (i.e. the two primers 
that would disrupt TLE stem integrity) led to a decrease in LysRS affinity. This result 
also further raises the possibility that if LysRS does remain bound after primer annealing, 
it is likely remodeled out of the complex once reverse transcription initiates.  
This study has helped to further our understanding of how and when human LysRS 
interacts with the HIV-1 PBS domain. However, further studies in cell culture will be 
required to confirm the precise timing of tRNA placement, and the viral life cycle stages 
in which LysRS is present in the HIV-1 reverse transcription initiation complex.  
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